New factory takes AGC Danmark to another level within the corporation

Demand for medication production is now so high that AGC Biologics' Danish unit expects to sell the output of almost full production capacity at the company's new factory within three years after commissioning, expectedly in 2023.

Construction of the new factory in Copenhagen is a major project for AGC Biologics, both locally and for the group as a whole. Opførslen af en ny fabrik i København er et stort projekt for AGC Biologics, både lokalt og for koncernen som hele. Photo shows, from left to right, Technical Director Kasper Møller, Copenhagen Site Lead Andrea Porchia, and VP of Technical Operations Christian Christensen. | Photo: Lars Thornblad

When AGC Biologics' new production facilities enter operation in 2023 and 300 new personnel are hired, the Danish division will be among the largest within the corporation, says Copenhagen Site Head Andrea Porchia.

"Within AGC Biologics, we will clearly become one of the largest production units with this new factory, but expansions are also taking pace at other sites, so it's difficult to say precisely where we will land, but it will be around the top," she says.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs